ReviewAntiviral chemistry & chemotherapy2017

Metabolic reprogramming during hepatitis B disease progression offers novel diagnostic and therapeutic opportunities.

Jesse Jr Masson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.